Lilly Announces Details of Presentations at 2021 American Association for Cancer Research (AACR)
The Pharma Data
MARCH 11, 2021
Retevmo was approved under the FDA’s Accelerated Approval regulations based on the LIBRETTO-001 Phase 1/2 trial’s endpoints of overall response rate (ORR) and duration of response (DoR). FDA-approved oral prescription medicine, 120 mg or 160 mg dependent on weight (<50 kg or ?50
Let's personalize your content